Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 8/20 | 1.00 |
| ▸ | PTPRC | P08575 | 2/20 | 0.89 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | MEN1 | O00255 | 3/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | CDC25A | P30304 | 1/20 | 0.67 |
| ▸ | CDC25B | P30305 | 1/20 | 0.67 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 4/20 | 0.65 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.62 |
| ▸ | HTR7 | P34969 | 1/20 | 0.57 |
| ▸ | HTR2B | P41595 | 1/20 | 0.57 |
| ▸ | S100A4 | P26447 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30610011 | 1.00 | TTR (1.00) | TTRPTPRCKMT2AMAPTMEN1 | |
| SCHEMBL28081049 | 0.98 | TTR (0.96) | TTRPTPRCKMT2AMAPTMEN1 | |
| SCHEMBL28197847 | 0.98 | TTR (0.96) | TTRPTPRCKMT2AMAPTMEN1 | |
| SCHEMBL29917994 | 0.98 | TTR (0.96) | TTRPTPRCKMT2AMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL3453762 | 0.98 | TTR (0.96) | TTRPTPRCKMT2AMAPTMEN1 | |
| SCHEMBL11877439 | 0.98 | TTR (0.96) | TTRPTPRCKMT2AMAPTMEN1 | |
| SCHEMBL292802 | 0.98 | TTR (0.96) | TTRPTPRCKMT2AMAPTMEN1 | |
| SCHEMBL28446002 | 0.98 | TTR (0.96) | TTRPTPRCKMT2AMAPTMEN1 | |
| SCHEMBL3100326 | 0.94 | PTPRC (0.92) | TTRPTPRCKMT2AMAPTMEN1 | |
| SCHEMBL6261915 | 0.94 | PTPRC (1.00) | TTRPTPRCKMT2AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250387524-A1 | METHOD AND SYSTEM FOR THE PRODUCTION OF DISINFECTION AND/OR STERILISATION SOLUTIONS | ESTEVEZ COMPANY CARLOS (ES) | 2025-12-25 | — | — | US | claimed |
| US-12466869-B2 | Targeting of multiple antigens with multiplex CAR T cells in solid and liquid malignancies | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2025-11-11 | — | — | US | claimed |
| CN-119432385-B | Carbon-based material, preparation method and application thereof | 广东省科学院生态环境与土壤研究所 | 2025-06-17 | — | — | CN | claimed |
| EP-4549429-A1 | METHOD AND SYSTEM FOR THE PRODUCTION OF DISINFECTION AND/OR STERILISATION SOLUTIONS | Universitat Jaume I (ES) | 2025-05-07 | — | — | EP | claimed |
| CN-119432385-A | Carbon-based material, preparation method and application thereof | 广东省科学院生态环境与土壤研究所 | 2025-02-14 | — | — | CN | claimed |
| US-20240408139-A1 | ENGINEERED CYTOKINE RECEPTORS FOR TUNABLE ADOPTIVE CELL THERAPY | DANA-FARBER CANCER INSTITUTE, INC. | 2024-12-12 | — | — | US | claimed |
| CN-118870853-A | Chemical molecule modified perovskite passivation structure, solar cell, light-emitting diode and photoelectric detector preparation method | 中国科学技术大学 | 2024-10-29 | — | — | CN | claimed |
| CN-113814575-B | Laser cutting protection liquid and preparation method and application thereof | 深圳市化讯半导体材料有限公司 | 2024-09-03 | — | — | CN | claimed |
| EP-4413029-A1 | ENGINEERED CYTOKINE RECEPTORS FOR TUNABLE ADOPTIVE CELL THERAPY | Dana-Farber Cancer Institute, Inc. (US) | 2024-08-14 | — | — | EP | claimed |
| CN-118343881-A | Method for catalyzing degradation of organic pollutants by visible light driven anthraquinone and derivatives thereof | 重庆文理学院 | 2024-07-16 | — | — | CN | claimed |
| US-5430067-A | Dihydroanthraquinonecarboxylic acids | ELI LILLY AND COMPANY (US) | 1995-07-04 | — | — | US | claimed |
| EP-0638540-A1 | Pharmaceutical anthracene-2-carboxylic acid derivatives | LILLY INDUSTRIES LIMITED (GB) | 1995-02-15 | — | — | EP | claimed |
| US-5389700-A | Complex of a charge transfer compound conisting of a biscyclopentadienyl iron compound and a quinoid and a salt | AUTEX, INC. (JP) | 1995-02-14 | — | — | US | claimed |
| US-5358664-A | Oil, aluminum soap complex, synthetic oil; buffer tube gels and fillers for waveguides | CASCHEM, INC. (US) | 1994-10-25 | — | — | US | claimed |
| CN-1090596-A | Gelled oil compositions | CASCHEM INC (US) | 1994-08-10 | — | — | CN | claimed |
| EP-0525073-B1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | DU PONT (US) | 1994-05-25 | — | — | EP | claimed |
| EP-0540371-A1 | Initiator for photopolymerization | AUTEX, INC. (JP) | 1993-05-05 | — | — | EP | claimed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | claimed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | claimed |
| US-4145356-A | CRYSTALLIZATION IN SOLVENT CONTAINING AN ANTHRAQUINONE COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 1979-03-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12466869-B2 | Targeting of multiple antigens with multiplex CAR T cells in solid and liquid malignancies | CD47, CD2, TP53 | TTR 1284/4885PTPRC 99/4885KMT2A 265/4885 |
| US-20250387524-A1 | METHOD AND SYSTEM FOR THE PRODUCTION OF DISINFECTION AND/OR STERILISATION SOLUTIONS | HAO2, PDK3, ADH1C | TTR 3930/4885PTPRC 1250/4885KMT2A 2727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.